TELA
Income statement / Annual
Last year (2023), TELA Bio, Inc.'s total revenue was $58.45 M,
an increase of 41.13% from the previous year.
In 2023, TELA Bio, Inc.'s net income was -$46.66 M.
See TELA Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
Operating Revenue |
$58.45 M |
$41.42 M |
$29.46 M |
$18.21 M |
$15.45 M |
$8.27 M |
$4.25 M |
Cost of Revenue |
$18.34 M
|
$14.37 M
|
$10.65 M
|
$6.98 M
|
$6.17 M
|
$5.33 M
|
$1.71 M
|
Gross Profit |
$40.11 M
|
$27.04 M
|
$18.81 M
|
$11.23 M
|
$9.27 M
|
$2.94 M
|
$2.53 M
|
Gross Profit Ratio |
0.69
|
0.65
|
0.64
|
0.62
|
0.6
|
0.36
|
0.6
|
Research and Development Expenses |
$9.62 M
|
$8.94 M
|
$6.74 M
|
$4.26 M
|
$4.15 M
|
$4.34 M
|
$5.79 M
|
General & Administrative Expenses |
$14.89 M
|
$13.86 M
|
$12.46 M
|
$10.14 M
|
$6.22 M
|
$4.90 M
|
$4.96 M
|
Selling & Marketing Expenses |
$59.68 M
|
$43.25 M
|
$29.06 M
|
$22.11 M
|
$18.06 M
|
$13.65 M
|
$8.71 M
|
Selling, General & Administrative Expenses |
$74.57 M
|
$57.11 M
|
$41.52 M
|
$32.25 M
|
$24.28 M
|
$18.55 M
|
$13.67 M
|
Other Expenses |
$0.00
|
-$10,000.00
|
-$228,000.00
|
$45,000.00
|
$351,000.00
|
$70,000.00
|
$94,000.00
|
Operating Expenses |
$84.19 M
|
$66.05 M
|
$48.26 M
|
$36.51 M
|
$28.43 M
|
$22.88 M
|
$19.46 M
|
Cost And Expenses |
$102.53 M
|
$80.43 M
|
$58.91 M
|
$43.49 M
|
$34.61 M
|
$28.22 M
|
$21.17 M
|
Interest Income |
$0.00
|
$4.05 M
|
$3.60 M
|
$3.56 M
|
$3.61 M
|
$0.00
|
$0.00
|
Interest Expense |
$5.22 M
|
$4.05 M
|
$3.60 M
|
$3.56 M
|
$3.61 M
|
$1.80 M
|
$4.56 M
|
Depreciation & Amortization |
$808,000.00
|
$1.19 M
|
$535,000.00
|
$525,000.00
|
$582,000.00
|
$1.25 M
|
$761,000.00
|
EBITDA |
-$40.63 M |
-$39.06 M |
-$29.14 M |
-$24.71 M |
-$18.23 M |
-$18.04 M |
-$16.02 M |
EBITDA Ratio |
-0.7
|
-0.94
|
-1.01
|
-1.39
|
-1.22
|
-2.25
|
-3.79
|
Operating Income Ratio |
-0.75
|
-0.94
|
-1
|
-1.39
|
-1.24
|
-2.15
|
-3.99
|
Total Other Income/Expenses Net |
-$2.59 M
|
-$5.29 M
|
-$3.83 M
|
-$3.52 M
|
-$3.26 M
|
-$3.31 M
|
-$4.41 M
|
Income Before Tax |
-$46.66 M
|
-$44.30 M
|
-$33.28 M
|
-$28.79 M
|
-$22.43 M
|
-$21.09 M
|
-$21.33 M
|
Income Before Tax Ratio |
-0.8
|
-1.07
|
-1.13
|
-1.58
|
-1.45
|
-2.55
|
-5.03
|
Income Tax Expense |
$0.00
|
$41,000.00
|
$2.83 M
|
$3.08 M
|
$3.38 M
|
-$1.51 M
|
$4.65 M
|
Net Income |
-$46.66 M
|
-$44.34 M
|
-$36.11 M
|
-$31.88 M
|
-$25.80 M
|
-$21.09 M
|
-$21.33 M
|
Net Income Ratio |
-0.8
|
-1.07
|
-1.23
|
-1.75
|
-1.67
|
-2.55
|
-5.03
|
EPS |
-2.04 |
-2.73 |
-2.49 |
-2.46 |
-2.26 |
-3.25 |
-3.29 |
EPS Diluted |
-2.04 |
-2.73 |
-2.49 |
-2.46 |
-2.26 |
-3.25 |
-3.29 |
Weighted Average Shares Out |
$22.87 M
|
$16.27 M
|
$14.47 M
|
$12.93 M
|
$11.41 M
|
$6.49 M
|
$6.49 M
|
Weighted Average Shares Out Diluted |
$22.87 M
|
$16.27 M
|
$14.47 M
|
$12.93 M
|
$11.41 M
|
$6.49 M
|
$6.49 M
|
Link |
|
|
|
|
|
|
|